. 2002 Oct 10;1:1. doi: 10.1186/1475-2883-1-1

Table 5.

Day specific prevalence and intensity of Og4C3 in the three drug groups.

Day	Prevalence (%)			Mean Intensity of OD values^a
	Alb	DEC	Alb + DEC	Alb	DEC	Alb + DEC

0 (pre-therapy)	94.7	88.2	94.1	0.49 (± 0.16)	0.39 (± 0.21)	0.47 (± 0.18)
7	94.7^†	87.5^†	88.2^†	0.47^† (± 0.19)	0.40^† (± 0.22)	0.44^† (± 0.25)
360	15.8**	17.6**	17.6**	0.08** (± 0.17)	0.07** (± 0.15)	0.08** (± 0.15)

^a Data are mean ± SD. †P = non significant vs. day 0 (pre-therapy) **P = < 0.01 vs. day 0 (pre-therapy) Alb = albendazole, DEC = diethylcarbamazine citrate, Alb + DEC = albendazole + diethylcarbamazine citrate